3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Neoplasms
3
Uterine Cervical Neoplasms
2
Camurati-Engelmann Syndrome
2
Triple Negative Breast Neoplasms
1
Metastatic Solid Tumors
1
Lung Neoplasms
1
Gallbladder Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Injections
2
Infusions, Intravenous
2
tislelizumab
1
sacituzumab govitecan
1
bintrafusp alfa protein, human
1
avelumab
1
Platinum
1
Gemcitabine
1
DOXO-EMCH
1
Cetuximab
1
(2,4-dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Metastatic Solid Tumors
×
bintrafusp alfa protein, human
×
Clear all
NCT04457778
2026-05-04
First in Human Study of M6223
EMD Serono
Phase 1
Completed
58 enrolled
38 charts